This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Goodall G, Jendle JH, Valentine WJ, Munro V, Brandt AB, Ray JA, Roze S, Foos V, Palmer AJ.Biphasic insulin aspart 70/30 vs. insulin glargine in insulin naive type 2 diabetes patients: modelling the long-term health economic implications in a Swedish setting. International Journal of Clinical Practice 62: 869-876, No. 6, Jun 2008
Rights and permissions
About this article
Cite this article
Biphasic insulin aspart lifesaving and cost saving in Sweden. Pharmacoecon. Outcomes News 558, 5 (2008). https://doi.org/10.2165/00151234-200805580-00013
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200805580-00013